This is very encouraging news. Pills would be far cheaper to make, and more importantly, keep stable in high temperature African environments — much less “special handling” than existing monoclonal antibodies.

And so, the latest is here:

…Monkeys infected with the deadly Ebola virus have been successfully cured by a 10-day regimen of pills, leading scientists to hope the treatment could be adapted for use in humans. The drug, obeldesivir, offers a substantial advantage over the two other FDA-approved treatments for Ebola as they have to be delivered via an IV drip, whereas pills are much more convenient to store and administer….

The drug is similar to remdesivir, an antiviral that’s used against a range of infections including COVID-19. It works by inhibiting the function of important viral enzymes called polymerases, blocking virus replication….

Onward. We just need USAID to be freed up to provide the funding for it — for the world. Yikes.

नमस्ते